Correlation Between Genfit and Tarsus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Genfit and Tarsus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genfit and Tarsus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genfit and Tarsus Pharmaceuticals, you can compare the effects of market volatilities on Genfit and Tarsus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genfit with a short position of Tarsus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genfit and Tarsus Pharmaceuticals.
Diversification Opportunities for Genfit and Tarsus Pharmaceuticals
-0.61 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Genfit and Tarsus is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Genfit and Tarsus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tarsus Pharmaceuticals and Genfit is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genfit are associated (or correlated) with Tarsus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tarsus Pharmaceuticals has no effect on the direction of Genfit i.e., Genfit and Tarsus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Genfit and Tarsus Pharmaceuticals
Given the investment horizon of 90 days Genfit is expected to generate 0.82 times more return on investment than Tarsus Pharmaceuticals. However, Genfit is 1.22 times less risky than Tarsus Pharmaceuticals. It trades about -0.01 of its potential returns per unit of risk. Tarsus Pharmaceuticals is currently generating about -0.04 per unit of risk. If you would invest 380.00 in Genfit on November 5, 2024 and sell it today you would lose (7.00) from holding Genfit or give up 1.84% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Genfit vs. Tarsus Pharmaceuticals
Performance |
| Timeline |
| Genfit |
| Tarsus Pharmaceuticals |
Genfit and Tarsus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Genfit and Tarsus Pharmaceuticals
The main advantage of trading using opposite Genfit and Tarsus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genfit position performs unexpectedly, Tarsus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tarsus Pharmaceuticals will offset losses from the drop in Tarsus Pharmaceuticals' long position.| Genfit vs. HCW Biologics | Genfit vs. Molecular Partners AG | Genfit vs. MediciNova | Genfit vs. Anebulo Pharmaceuticals |
| Tarsus Pharmaceuticals vs. Aldeyra | Tarsus Pharmaceuticals vs. Travere Therapeutics | Tarsus Pharmaceuticals vs. Eton Pharmaceuticals | Tarsus Pharmaceuticals vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |